Skip to main content
Top
Published in: Head & Neck Oncology 1/2009

Open Access 01-12-2009 | Review

Refeeding syndrome – awareness, prevention and management

Authors: Hisham Mehanna, Paul C Nankivell, Jamil Moledina, Jane Travis

Published in: Head & Neck Oncology | Issue 1/2009

Login to get access

Abstract

Background

Refeeding syndrome is an important, yet commonly overlooked condition affecting patients. It occurs when feeding is commenced after a period of starvation. Head and neck cancer patients are at particular risk owing to prolonged periods of poor nutritional intake. This may be from general effects such as cancer anorexia or from more specific problems of dysphagia associated with this group of patients. Awareness of the condition is crucial in identifying patients at risk and taking measures to prevent its occurrence.

Objectives

The aims of this review are to:
1) Highlight the condition and stress the importance of its consideration when admitting head and neck cancer patients.
2) Discuss the pathophysiology behind refeeding syndrome.
3) Review the literature for the best available evidence and guidelines.
4) Highlight the need for further high quality research.

Conclusion

Refeeding syndrome is potentially fatal, yet is preventable. Awareness and identification of at-risk patients is crucial to improving management.
Refeeding syndrome is caused by rapid refeeding after a period of under-nutrition, characterised by hypophosphataemia, electrolyte shifts and has metabolic and clinical complications.
High risk patients include the chronically under-nourished and those with little intake for greater than 10 days. Patients with dysphagia are at particular risk.
Refeeding should commence at 10 kcal/kg per day in patients at risk, and increased slowly. Thiamine, vitamin B complex and multi-vitamin supplements should be started with refeeding.
New NICE guidelines state that pre-feeding correction of electrolyte and fluid deficits is unnecessary, but should be done concurrently with re-feeding.
More research in this field is needed as the evidence base is lacking.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schnitker MA, Mattman PE, Bliss TL: A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med. 1951, 35: 69-96.CrossRefPubMed Schnitker MA, Mattman PE, Bliss TL: A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med. 1951, 35: 69-96.CrossRefPubMed
2.
go back to reference Crook MA, Hally V, Panteli JV: The importance of the refeeding syndrome. Nutrition. 2001, 17: 632-7. 10.1016/S0899-9007(01)00542-1.CrossRefPubMed Crook MA, Hally V, Panteli JV: The importance of the refeeding syndrome. Nutrition. 2001, 17: 632-7. 10.1016/S0899-9007(01)00542-1.CrossRefPubMed
4.
go back to reference Camp MA, Allon M: Severe hypophosphatemia in hospitalised patients. Mineral & Electrolyte Metabolism. 16 (6): 365-368. Camp MA, Allon M: Severe hypophosphatemia in hospitalised patients. Mineral & Electrolyte Metabolism. 16 (6): 365-368.
5.
go back to reference Marik PE, Bedigan MK: Refeeding Hypophosphataemia in an Intensive Care Unit: A Prospective Study. Arch Surg. 131: 1043-1047. Marik PE, Bedigan MK: Refeeding Hypophosphataemia in an Intensive Care Unit: A Prospective Study. Arch Surg. 131: 1043-1047.
6.
go back to reference Hayek ME, Eisenberg PG: Severe hypophosphatemia following the institution of enteral feedings. Arch Surg. 124: 1325-1328. Hayek ME, Eisenberg PG: Severe hypophosphatemia following the institution of enteral feedings. Arch Surg. 124: 1325-1328.
7.
go back to reference McCray S, Walker S, Parrish CR: Much ado about refeeding. Practical Gastroenterology. XXVIII (12): 26-44. McCray S, Walker S, Parrish CR: Much ado about refeeding. Practical Gastroenterology. XXVIII (12): 26-44.
8.
go back to reference Knochel JP: The clinical status of hypophosphatemia: an update. NEJM. 313: 447-449. Knochel JP: The clinical status of hypophosphatemia: an update. NEJM. 313: 447-449.
9.
go back to reference Wacker WEC, Parisi AF: Magnesium Metabolism. NEJM. 278: 658-663. Wacker WEC, Parisi AF: Magnesium Metabolism. NEJM. 278: 658-663.
10.
go back to reference Solomon R: The relationship between disorders of K+ and Mg+ homeostasis. Semin Nephrol. 7 (3): 253-62. Solomon R: The relationship between disorders of K+ and Mg+ homeostasis. Semin Nephrol. 7 (3): 253-62.
11.
go back to reference Klein CJ, Stanek GS, Wiles CE: Overfeeding macronutrients to critically ill adults. J AmDiet Assoc. 98: 795-806. 10.1016/S0002-8223(98)00179-5. Klein CJ, Stanek GS, Wiles CE: Overfeeding macronutrients to critically ill adults. J AmDiet Assoc. 98: 795-806. 10.1016/S0002-8223(98)00179-5.
12.
go back to reference Reuler JB, Girard DE, Cooney TG: Wernicke's encephalopathy. NEJM. 312: 1035-1039. Reuler JB, Girard DE, Cooney TG: Wernicke's encephalopathy. NEJM. 312: 1035-1039.
13.
go back to reference Veverbrants E, Arky RA: Effects of fasting and refeeding: I. Studies on sodium, potassium and water excretion on a constant electrolyte and fluid intake. J Clin Endocrinol Metab. 29: 55-62. Veverbrants E, Arky RA: Effects of fasting and refeeding: I. Studies on sodium, potassium and water excretion on a constant electrolyte and fluid intake. J Clin Endocrinol Metab. 29: 55-62.
14.
go back to reference National Institute for Health and Clinical Excellence: Nutrition support in adults. Clinical guideline CG32. 2006 National Institute for Health and Clinical Excellence: Nutrition support in adults. Clinical guideline CG32. 2006
15.
go back to reference Dewar H, Horvath R: Refeeding syndrome. A pocket guide to clinical nutrition. Edited by: Todorovic VE, Micklewright A. 2001, British Dietetic Association, 2 Dewar H, Horvath R: Refeeding syndrome. A pocket guide to clinical nutrition. Edited by: Todorovic VE, Micklewright A. 2001, British Dietetic Association, 2
Metadata
Title
Refeeding syndrome – awareness, prevention and management
Authors
Hisham Mehanna
Paul C Nankivell
Jamil Moledina
Jane Travis
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2009
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-1-4

Other articles of this Issue 1/2009

Head & Neck Oncology 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine